IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 51 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $5,538,680 | -89.3% | 5,240,000 | -90.1% | 0.20% | -87.6% |
Q3 2023 | $51,764,310 | +3.5% | 52,740,000 | 0.0% | 1.64% | +0.1% |
Q2 2023 | $50,004,113 | +3.9% | 52,740,000 | 0.0% | 1.63% | +3.0% |
Q1 2023 | $48,125,250 | -1.7% | 52,740,000 | 0.0% | 1.59% | -3.2% |
Q4 2022 | $48,949,313 | – | 52,740,000 | – | 1.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 127,800,000 | $128,518,000 | 2.56% |
WOLVERINE ASSET MANAGEMENT LLC | 107,030,000 | $106,622,000 | 1.15% |
MACKAY SHIELDS LLC | 24,472,000 | $24,283,000 | 0.61% |
SSI INVESTMENT MANAGEMENT LLC | 6,945,000 | $6,865,000 | 0.46% |
ADVENT CAPITAL MANAGEMENT /DE/ | 20,000,000 | $19,863,000 | 0.36% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 15,500,000 | $15,433,000 | 0.35% |
Magnetar Financial LLC | 16,700,000 | $16,606,000 | 0.23% |
CAMDEN ASSET MANAGEMENT L P /CA | 4,300,000 | $4,249,000 | 0.14% |
CAPSTONE INVESTMENT ADVISORS, LLC | 18,700,000 | $18,571,000 | 0.11% |
RWC Asset Management LLP | 2,500,000 | $2,497,000 | 0.08% |